2,443 results on '"Gores, Gregory J"'
Search Results
2. PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice
3. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
4. Cholangiocarcinoma — novel biological insights and therapeutic strategies
5. Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
6. Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinoma
7. Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinoma
8. Transposon-based oncogene integration in Abcb4(Mdr2)-/- mice recapitulates high susceptibility to cholangiocarcinoma in primary sclerosing cholangitis
9. TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial
10. Augmented Curation of Unstructured Clinical Notes from a Massive EHR System Reveals Specific Phenotypic Signature of Impending COVID-19 Diagnosis
11. Fibroblasts in liver cancer: functions and therapeutic translation
12. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
13. The Epigenetic Reader, Bromodomain Containing 2, Mediates Cholangiocyte Senescence via Interaction With ETS Proto-Oncogene 1
14. Transcriptomic landscapes of effective and failed liver regeneration in humans
15. FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations
16. Prognostication of ß-catenin (CTNNB1) in patients with HCC treated with first line immunotherapy.
17. Controversy Over Liver Transplantation or Resection for Neuroendocrine Liver Metastasis: Tumor Biology Cuts the Deal
18. Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients
19. Algebraic topology-based machine learning using MRI predicts outcomes in primary sclerosing cholangitis
20. Comparative Performance of Quantitative and Qualitative Magnetic Resonance Imaging Metrics in Primary Sclerosing Cholangitis
21. LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma
22. Incidence and Long-Term Outcomes of Biliary Tract Cancers in Olmsted County, Minnesota from 1976 to 2018.
23. Cholangiocarcinoma — evolving concepts and therapeutic strategies
24. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) deletion in myeloid cells augments cholestatic liver injury
25. Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System
26. Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines
27. Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study
28. Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells
29. IL-17 signaling in primary sclerosing cholangitis patient-derived organoids.
30. Living Donor Liver Transplantation for Perihilar Cholangiocarcinoma: Outcomes and Complications
31. Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis
32. Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor Deficiency Promotes the Ductular Reaction, Macrophage Accumulation, and Hepatic Fibrosis in the Abcb4−/− Mouse
33. Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine
34. Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy
35. Deregulated methionine adenosyltransferase α1, c‐Myc, and Maf proteins together promote cholangiocarcinoma growth in mice and humans‡
36. Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans
37. Introducing the Editorial Fellow and the Fellows’ Corner
38. Precipitous changes in nomenclature and definitions—NAFLD becomes SLD: Implications for and expectations of AASLD journals
39. Corrigendum to “EASL-ILCA clinical practice guidelines on the management of intrahepatic cholangiocarcinoma” [J Hepatol (79) (2023) 181–208]
40. IL-17 Signaling in Primary Sclerosing Cholangitis Patient-Derived Organoids
41. Liver Transplantation for Peri-hilar Cholangiocarcinoma
42. Mistiming Death: Modeling the Time-Domain Variability of Tumor Apoptosis and Implications for Molecular Imaging of Cell Death
43. Cholangiocarcinoma
44. Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
45. Immunobiology of cholangiocarcinoma
46. Cholangiocarcinoma 2020: the next horizon in mechanisms and management
47. Cholangioscopy Biopsies Improve Detection of Cholangiocarcinoma When Combined with Cytology and FISH, but Not in Patients with PSC
48. An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort
49. IL‐33 facilitates oncogene‐induced cholangiocarcinoma in mice by an interleukin‐6‐sensitive mechanism
50. A global view of hepatocellular carcinoma: trends, risk, prevention and management
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.